Regencell Bioscience Holdings RGC
NASDAQ RGC
$10.45 +0.40 (+3.98%)
At close: Oct 20, 2026 · 4:00 PM EDT

Regencell Bioscience Holdings (RGC) Debt Ratio (2020 - 2026)

Updated

Regencell Bioscience Holdings' Debt Ratio was 0.00 in the quarter ended Jun 30, 2026, up 66.0% from 0.00 a year earlier.

Analysis

Regencell Bioscience Holdings (RGC) Debt Ratio (2020 - 2026) Analysis & Trends

From the quarter ended Jun 30, 2020 onward, Regencell Bioscience Holdings has reported Debt Ratio for 5 quarters.

  • In earlier years, Debt Ratio was 0.00 in the year ended Jun 30, 2025 and 0.00 in the year ended Jun 30, 2023.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Debt Ratio since the quarter ended Jun 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 0.39
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 0.24
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 0.52
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 0.42
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 0.08
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 0.28
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 0.53
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 0.31
10 Regencell Bioscience Holdings 5.16 Bn 5.13 Bn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Jun 30, 2025 0.00
Jun 30, 2024 0.00
Jun 30, 2023 0.00
Jun 30, 2022 0.00
Jun 30, 2021 10.83
Jun 30, 2020 5.97
API Access

Regencell Bioscience Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RGC&period=max&api_key=YOUR_API_KEY